Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Not yet recruiting 2Unknown 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Pancreatic Neoplasms 12Carcinoma, Non-Small-Cell Lung 6Breast Neoplasms 5Triple Negative Breast Neoplasms 4Stomach Neoplasms 4Ovarian Neoplasms 3Neoplasm Metastasis 3Fallopian Tube Neoplasms 3Advanced Pancreatic Cancer 3Esophageal Neoplasms 2Biliary Tract Neoplasms 2Uterine Neoplasms 1Uterine Cervical Neoplasms 1Staging IV NSCLC 1Squamous Cell Carcinoma of Lung 1Solid Tumor 1Sertoli-Leydig Cell Tumor 1Recurrence 1Peritoneal Neoplasms 1Pancreatic Cancer Non-resectable 1Pancreatic Adenocarcinoma 1Ovarian gynandroblastoma 1Obesity 1Neurotoxicity Syndromes 1Neoplasms 1Nasopharyngeal Neoplasms 1Nasopharyngeal Carcinoma 1Liver Neoplasms 1HER2-negative Breast Cancer 1HER2+ Breast Cancer 1

Interventions

Cisplatin 51Gemcitabine 24Radiotherapy, Intensity-Modulated 21Docetaxel 20Fluorouracil 15camrelizumab 12Drug Therapy 11Radiotherapy 10toripalimab 8Chemoradiotherapy 8Capecitabine 8apatinib 7Induction Chemotherapy 7nimotuzumab 6endostar protein 6Endostatins 6sintilimab 5nedaplatin 5Bevacizumab 5fludarabine 4Cyclophosphamide 4spartalizumab 3fludarabine phosphate 3cisplatin-guanosine adduct 3SSRP1 protein, human 3Paclitaxel 3Injections 3Endoscopy 3tislelizumab 2Vitamin B 12 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Nasopharyngeal Carcinoma × Taxes × Clear all
NCT04769076 2021-02-25

The Paclitaxel (Albumin-bound) Combined With Cisplatin, PD-1 Inhibitors and IMRT in the Treatment of Nasopharyngeal Carcinoma

The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

Phase 2 Unknown
40 enrolled
Head & Neck

Nasopharyngeal Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡